Alba Sánchez Velázquez-rekin lankidetzan egindako argitalpenak (11)

2024

  1. Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases

    Journal of the European Academy of Dermatology and Venereology

2022

  1. Eczematous reactions induced by anti-IL17 agents: Report of two cases and possible pathogenic mechanisms

    Indian Journal of Dermatology

  2. Real-life experience of using pegylated liposomal doxorubicin in primary cutaneous T-cell lymphomas

    Clinical and Experimental Dermatology, Vol. 47, Núm. 9, pp. 1712-1715

  3. Romidepsin-induced sterile folliculitis in a patient with Sézary syndrome

    International Journal of Dermatology

  4. Single-centre experience of using pegylated liposomal doxorubicin as maintenance treatment in mycosis fungoides

    British Journal of Dermatology

  5. Two cases of generalized eruptive lentiginosis in cutaneous T-cell lymphoma following mogamulizumab treatment

    International Journal of Dermatology

  6. Two clinical subtypes with different management of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A single centre experience

    Dermatologic Therapy

2021

  1. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology

2020

  1. COVID-19-related acute genital ulcers

    Journal of the European Academy of Dermatology and Venereology

2019

  1. Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report

    Dermatologic Therapy, Vol. 32, Núm. 2

  2. Psoriatic alopecia-like paradoxical reaction to certolizumab pegol

    International Journal of Dermatology